Old Web
English
Sign In
Acemap
>
authorDetail
>
Xavier Quantin
Xavier Quantin
French Institute of Health and Medical Research
Medicine
Oncology
Internal medicine
Osimertinib
Lung cancer
3
Papers
54
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Five-year survival outcomes with durvalumab after chemoradiotherapy in unresectable stage III NSCLC: An update from the PACIFIC trial.
2021
Journal of Clinical Oncology
David R. Spigel
Corinne Faivre-Finn
Jhanelle E. Gray
David Vicente
David Planchard
Luis Paz-Ares
Johan Vansteenkiste
Marina Chiara Garassino
Rina Hui
Xavier Quantin
Andreas Rimner
Yi-Long Wu
Mustafa Ozguroglu
Ki Hyeong Lee
Terufumi Kato
Maike de Wit
Euan Macpherson
Michael Newton
P Thiyagarajah
Scott J. Antonia
Show All
Source
Cite
Save
Citations (13)
Combination of tissue and liquid biopsy molecular profiling to detect transformation to small cell lung carcinoma during osimertinib treatment.
2020
Therapeutic Advances in Medical Oncology
Julie A. Vendrell
Xavier Quantin
Isabelle Serre
Jérôme Solassol
Show All
Source
Cite
Save
Citations (4)
FDA- and EMA-Approved Tyrosine Kinase Inhibitors in Advanced EGFR-Mutated Non-Small Cell Lung Cancer: Safety, Tolerability, Plasma Concentration Monitoring, and Management
2019
Isabelle Solassol
Frédéric Pinguet
Xavier Quantin
Show All
Source
Cite
Save
Citations (37)
1